The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?

References

• Bratan F, Niaf E, Melodelima C, et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric M.R.I.: a prospective study. Eur Radiol. 2013;23:2019–2029.
   PubMed Web of Science ®Google Scholar
• Gupta RT, Kauffman CR, Polascik TJ, et al. The state of prostate M.R.I. in 2013. Oncology (W.I.lliston Park, N.Y.) 2013;27:262–270.
   PubMed Web of Science ®Google Scholar
• Weinreb JC, Barentsz JO, Choyke PL, et al. P.I.-R.A.D.S. Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69:16–40.
   PubMed Web of Science ®Google Scholar
• Valerio M, Donaldson I, Emberton M, et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2015;68:8–19.
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Verma S, Choyke P, et al. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients W.I.th a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol. 2016;196:1613–1618.
   PubMed Web of Science ®Google Scholar
• Wegelin O, van Melick HHE, Hooft L, et al. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique. Eur Urol. 2017;71:517–531.
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Rannikko AS, Borghi M, et al. M.R.I.-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378:1767–1777.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric M.R.I. and T.R.U.S. biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017;389:815–822.
   PubMed Web of Science ®Google Scholar
• Rouse P, Shaw G, Ahmed HU, et al. Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int. 2011;87:49–53.
   PubMed Web of Science ®Google Scholar
• Numao N, Yoshida S, Komai Y, et al. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men W.I.th suspected clinically localized prostate cancer. J Urol. 2013;190:502–508.
   PubMed Web of Science ®Google Scholar
• Rais-Bahrami S, Siddiqui MM, Turkbey B, et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013;190:1721–1727.
   PubMed Web of Science ®Google Scholar
• Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22:746–757.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 International Society of Urological Pathology (I.S.U.P.) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228–1242.
   PubMed Web of Science ®Google Scholar
• Cooperberg MR, Broering JM, Kantoff PW, et al. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178:S14–S19.
   PubMed Web of Science ®Google Scholar
• Bjurlin MA, Carter HB, Schellhammer P, et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol. 2013;189:2039–2046.
   PubMed Web of Science ®Google Scholar
• Barentsz JO, Weinreb JC, Verma S, et al. Synopsis of the P.I.-R.A.D.S. v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016;69:41
   PubMed Web of Science ®Google Scholar
• Wang RS, Kim EH, Vetter JM, et al. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary. Urology 2017;102:190–197.
   PubMed Web of Science ®Google Scholar
• Itatani R, Namimoto T, Atsuji S, et al. Negative predictive value of multiparametric M.R.I. for prostate cancer detection: outcome of 5-year follow-up in men W.I.th negative findings on initial M.R.I. studies. Eur J Radiol. 2014;83:1740–1745.
   PubMed Web of Science ®Google Scholar
• Pokorny MR, de Rooij M, Duncan E, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging W.I.th subsequent MR-guided biopsy in men W.I.thout previous prostate biopsies. Eur Urol. 2014;66:22–29.
   PubMed Web of Science ®Google Scholar
• Moldovan PC, Van den Broeck T, Sylvester R, et al. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur Urol. 2017;72:250–266.
   PubMed Web of Science ®Google Scholar
• Vinet M, Vlaeminck-Guillem V, Rouvière O, et al. Does P.C.A3 score and prostatic M.R.I. help selection of patients scheduled for initial prostatic biopsy? Prog Urol. 2013;23:121–127.
   PubMed Web of Science ®Google Scholar
• Thompson JE, Moses D, Shnier R, et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol. 2014;192:67–74.
   PubMed Web of Science ®Google Scholar
• Radtke JP, Kuru TH, Boxler S, et al. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy W.I.th magnetic resonance imaging-ultrasound fusion guidance. J Urol. 2015;193:87–94.
   PubMed Web of Science ®Google Scholar
• Grenabo Bergdahl A, W.I.lderäng U, Aus G, et al. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study W.I.thin the Göteborg Randomised Screening Trial. Eur Urol. 2016;70:566–573.
   PubMed Web of Science ®Google Scholar
• Hauth E, Hohmuth H, Cozub-Poetica C, et al. Multiparametric M.R.I. of the prostate W.I.th three functional techniques in patients W.I.th P.S.A. elevation before initial T.R.U.S.-guided biopsy. Br J Radiol. 2015;88:20150422
   PubMed Web of Science ®Google Scholar
• Mannaerts CK, Gayet M, Verbeek JF, et al. Prostate Cancer Risk assessment in Biopsy-naive Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (T.R.U.S.) Fusion Biopsy and Systematic T.R.U.S. Biopsy. Eur Urol Oncol. 2018;1:109–117.
   PubMedGoogle Scholar
• Panebianco V, Barchetti G, Simone G, et al. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What’s Next?. Eur Urol. 2018;74:48–54.
   PubMed Web of Science ®Google Scholar
• Garcia-Reyes K, Passoni NM, Palmeri ML, et al. Detection of prostate cancer W.I.th multiparametric M.R.I. (mpM.R.I.): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. 2015;40:134–142.
   PubMed Web of Science ®Google Scholar
• Serrao EM, Barrett T, Wadhwa K, et al. Investigating the ability of multiparametric M.R.I. to exclude significant prostate cancer prior to transperineal biopsy. Cuaj. 2015;9:853–858.
   Google Scholar
• Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment W.I.th Curative Intent. Eur Urol. 2017;71:618–629.
   PubMed Web of Science ®Google Scholar